NEWS & EVENTS

OUR LATEST NEWS

March 24, 2023

ABL APPOINTS STEPHANIE COLLOUD AS GENERAL MANAGER AND CHIEF OPERATING OFFICER TO LEAD EUROPEAN ACTIVITIES

Read more


October 25, 2022

ABL AND RD-BIOTECH SIGN STRATEGIC PARTNERSHIP IN CELL AND GENE THERAPY GMP MANUFACTURING

Read more


October 18, 2022

ABL AND IMUGENE PARTNER TO ADVANCE ONCOLYTIC VIRUS CANDIDATE TOWARDS LATER PHASE CLINICAL TRIALS

Read more


July 11, 2022

ABL PARTNERS WITH KALIVIR IMMUNOTHERAPEUTICS TO ADVANCE DEVELOPMENT OF ONCOLYTIC VIRUSES

Read more